Synedgen Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Synedgen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10658
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Synedgen Inc (Synedgen) is a biotechnology company that discovers and develops polysaccharide-based drugs, which enhance and mimic the innate immune system. The company’s pipeline products include SYGN305, SYGN399, SYGN303, SYGN313 and SYGN309. Synedgen develops products for the treatment of cystic fibrosis (CF) lung infection; pulmonary infection; COPD; CF obstruction; GI infection, inflammation, mucosal damage and radiation syndrome. It also provides wound care products. The company utilizes glycomics technology platform for cystic fibrosis and other pulmonary conditions to synspira. Synedgen is headquartered in Claremont, California, the US.

Synedgen Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Synedgen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synedgen Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Synedgen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synedgen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Synedgen Inc, Medical Devices Deals, 2012 to YTD 2018 9
Synedgen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Synedgen Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Synedgen Raises USD3 Million in Venture Financing 11
Synedgen Raises USD3 Million in Venture Financing 12
Synedgen Raises USD3.5 Million in Venture Financing 13
Synedgen Raises USD0.6 Million in Venture Financing 14
Synedgen Raises US$3.2 Million In Venture Financing 15
Partnerships 16
Synedgen Enters Into Research Agreement With Cincinnati Children’s Hospital Medical Center And University Of Alabama 16
Licensing Agreements 17
Synspira Enters into Licensing Agreement with Synedgen 17
Synedgen Enters Into Licensing Agreement With Europharma Concepts For Oral Care Products 18
Synedgen Inc – Key Competitors 19
Synedgen Inc – Key Employees 20
Synedgen Inc – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Corporate Communications 22
Sep 19, 2018: Synedgen names Kaveri Parker as Chief Business Officer 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Synedgen Inc, Pharmaceuticals & Healthcare, Key Facts 2
Synedgen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synedgen Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Synedgen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synedgen Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Synedgen Inc, Medical Devices Deals, 2012 to YTD 2018 9
Synedgen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Synedgen Raises USD3 Million in Venture Financing 11
Synedgen Raises USD3 Million in Venture Financing 12
Synedgen Raises USD3.5 Million in Venture Financing 13
Synedgen Raises USD0.6 Million in Venture Financing 14
Synedgen Raises US$3.2 Million In Venture Financing 15
Synedgen Enters Into Research Agreement With Cincinnati Children’s Hospital Medical Center And University Of Alabama 16
Synspira Enters into Licensing Agreement with Synedgen 17
Synedgen Enters Into Licensing Agreement With Europharma Concepts For Oral Care Products 18
Synedgen Inc, Key Competitors 19
Synedgen Inc, Key Employees 20

List of Figures
Synedgen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Synedgen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Synedgen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Synedgen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Synedgen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synedgen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Synedgen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synedgen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Synedgen Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Synedgen Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dohler GmbH:企業の戦略・SWOT・財務情報
    Dohler GmbH - Strategy, SWOT and Corporate Finance Report Summary Dohler GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Kolon Industries Inc (120110):企業の財務・戦略的SWOT分析
    Kolon Industries Inc (120110) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Petrichor Energy Inc (PTP):石油・ガス:M&Aディール及び事業提携情報
    Summary Petrichor Energy Inc (Petrichor Energy), formerly Odyssey Petroleum Corp is an oil and gas company that acquires, explores and develops oil and natural gas reserves in the Americas. The company provides projects such as Verba Field, Marble Falls Prospect, and others. It offes its services fo …
  • Recro Pharma Inc (REPH):企業の財務・戦略的SWOT分析
    Recro Pharma Inc (REPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Gulf Keystone Petroleum Ltd (GKP):石油・ガス:M&Aディール及び事業提携情報
    Summary Gulf Keystone Petroleum Ltd (Gulf Keystone) is an oil and gas company that offers operation and production of oil and natural gas reserves. The company operates working interests in the Republic of Algeria and the Kurdistan Region of Northern Iraq. Its Kurdistan Region of Iraq operates produ …
  • Mckinsey & Company, Inc.:企業の戦略・SWOT・財務分析
    Mckinsey & Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mckinsey & Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Trimedyne Inc (TMED):企業の戦略的SWOT分析
    Trimedyne Inc (TMED) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Softchoice Corporation:企業の戦略・SWOT・財務情報
    Softchoice Corporation - Strategy, SWOT and Corporate Finance Report Summary Softchoice Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Horama SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Horama SA (Horama) is a biotechnology company, which develops gene therapy products based on recombinant adeno-associated virus (rAAV) vectors for the treatment of rare ophthalmic diseases, including retinopathies and maculopathies. Its pipeline gene replacement products include HORA-RPE65, …
  • New Silkroad Culturaltainment Limited.:企業の戦略・SWOT・財務分析
    New Silkroad Culturaltainment Limited. - Strategy, SWOT and Corporate Finance Report Summary New Silkroad Culturaltainment Limited. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Life Time Fitness, Inc:企業の戦略・SWOT・財務情報
    Life Time Fitness, Inc - Strategy, SWOT and Corporate Finance Report Summary Life Time Fitness, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Zynerba Pharmaceuticals Inc (ZYNE):企業の財務・戦略的SWOT分析
    Summary Zynerba Pharmaceuticals Inc (Zynerba Pharmaceuticals), formerly AllTranz Inc, is a developer of next-generation synthetic cannabinoid therapeutics. The company provides pipeline product candidates such as ZYN002 and ZYN001. Its ZYN002 is a synthetic CBD, a non-euphoric cannabinoid, formulate …
  • Korea Gas Corp (036460):石油・ガス:M&Aディール及び事業提携情報
    Summary Korea Gas Corp (KOGAS) is a vertically integrated natural gas company active in upstream midstream and downstream segments of natural gas industry. It explores, produces and distributes natural gas. The company also purifies and sells by-products; imports and exports natural gas and liquefie …
  • OBB-Infrastruktur AG:企業の戦略的SWOT分析
    OBB-Infrastruktur AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • OriGene Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary OriGene Technologies Inc (OriGene) is a research tool company that develops cDNA. The company creates commercial collection of full-length human cDNAs in expression vector. It develops, manufactures and sells genome research and diagnostic products. OriGene’s products include qPCR reagents, …
  • University of Gothenburg:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Gothenburg is an educational institute that offers medical education and research services. The institute provides undergraduate, postgraduate, degree programs, and distance education programs. It offers courses in the fields of natural sciences, education teaching and learning …
  • Pharmacyclics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmacyclics Inc (Pharmacyclics), a wholly-owned subsidiary of AbbVie, discovers, develops and commercializes novel therapies for the treatment of cancer and immunemediated diseases. The company’s drugs and drug candidates are synthetic small-molecules that target major biochemical pathways …
  • NIKE Inc:企業の戦略・SWOT・財務情報
    NIKE Inc - Strategy, SWOT and Corporate Finance Report Summary NIKE Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Apache Corporation:戦略・SWOT・企業財務分析
    Apache Corporation - Strategy, SWOT and Corporate Finance Report Summary Apache Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • StemBioSys Inc-製薬・医療分野:企業M&A・提携分析
    Summary StemBioSys Inc (StemBioSys) is a biomedical company that concentrates on isolation, expansion and delivery of specialized adult stem cells. The company has developed high performance microenvironment for treating human diseases. Its HPME is an advanced stem cell culture system that creates n …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆